Glaukos (GKOS) Stock: Buy, Sell, or Hold?
GKOS - Glaukos Corporation
$173.43
6.47 (3.88%)
▲
5d:
+4.79%
30d:
+7.37%
90d:
+13.46%
WAIT
LOW Confidence
Analysis Updated: Oct 20, 2026 12:00 AM ET
Earnings: Oct 28, 2026
6d
Get Alerted When GKOS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: GKOS shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: GKOS shows conflicting indicators. Wait for confirmation before entering.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$18.31
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$11.37
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: GKOS is currently trading at $173.43, which is considered extended relative to its 30-day fair value range of $158.82 to $168.91. The stock's valuation (Forward PE: 331.7) is in line with its historical norms (304.8). At these levels, the market is pricing in 2.9% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, GKOS is in a strong uptrend. The price is approaching resistance at $176.07. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.9% recently.
Market Sentiment: GKOS scores 28/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (14th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $199.31 (+14.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, GKOS is in a strong uptrend. The price is approaching resistance at $176.07. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.9% recently.
Market Sentiment: GKOS scores 28/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (14th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $199.31 (+14.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$158.82 -
$168.91
Company Quality Score
44/100
(HOLD)
Options IV Signal
14th percentile
(LOW)
Volume Confirmation
HIGH
Confidence Score
45.0%
Protect Your Profits
Holding GKOS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Options cheap (IV 14th percentile)
- BEARISH: Weak technical setup (28/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.9%)
- BULLISH: Trading below Wall St target ($199.31)
- NEUTRAL: Market pricing in 2.9% annual earnings growth - fairly valued
- WARNING: Composite score 44/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$158.82 -
$168.91
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$15.73
(9.1%)
Support & Resistance Levels
Support Level
$146.39
Resistance Level
$176.07
Current Trend
Strong Uptrend
Technical data as of
Oct 20, 2026
Fundamental Context
Forward P/E (Next Year Est.)
331.73
Wall Street Target
$199.31
(+14.9%)
Revenue Growth (YoY)
49.5%
Earnings Growth (YoY)
1896.3%
Profit Margin
-30.7%
Valuation Premium vs History
+2.9% premium
PE vs Historical
331.7 vs 304.8
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+2.9%
(market-implied from PE analysis)
1-Year Target
$178.46
(+3%)
2-Year Target
$183.63
(+6%)
3-Year Target
$188.96
(+9%)
3-Yr Target (if PE normalizes)
(PE: 332→305)
PE COMPRESSION
$173.62
(+0%)
Earnings growth offset by PE compression
Share & Embed Analysis
Last updated: October 20, 2026 7:34 PM ET
Data refreshes hourly during market hours. Next update: 8:34 PM
Data refreshes hourly during market hours. Next update: 8:34 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is GKOS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$96 | 48 HOLD |
|
BSX
Boston Scientific Corp |
STRONG BUY
31 analysts |
$59 | 50 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$121 | 44 HOLD |
|
MDT
Medtronic PLC |
BUY
29 analysts |
$105 | 43 HOLD |
|
TNDM
Tandem Diabetes Care Inc |
BUY
25 analysts |
$28 | 60 HOLD |
Advanced GKOS Option Strategies
Professional options setups generated by AI based on today's GKOS price and gamma walls.
